Association of substance use and other psychiatric disorders with all-cause and external-cause mortality in individuals given community sentences in Sweden: a national cohort study.
Criminal justice
Mental health
Mortality
Premature mortality
Risk factors
Substance misuse
Suicide
Journal
The Lancet regional health. Europe
ISSN: 2666-7762
Titre abrégé: Lancet Reg Health Eur
Pays: England
ID NLM: 101777707
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
22
03
2023
revised:
11
07
2023
accepted:
12
07
2023
medline:
13
11
2023
pubmed:
13
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
Consistently high rates of premature mortality have been reported in individuals who receive community sentences. However, few studies have explored potential modifiable risk factors for these rates, particularly mental health. We examined the association of substance use and other psychiatric disorders with all-cause and external-cause mortality in individuals convicted of a criminal offence and given a community sentence. We did a longitudinal cohort study of 109,751 individuals given community sentences in Sweden using population-based registers. We calculated mortality rates for all-cause and external-cause mortality, hazard ratios for the association between psychiatric disorders and mortality, and population attributable fractions to quantify the contribution of psychiatric disorders to mortality risk. During the follow-up, 5749 (5.2%) individuals died, including 2709 (2.5%) from external causes. Individuals with pre-existing substance use and other psychiatric disorders had an increased mortality risk from any cause (aHR = 2.28 [95% CI 2.15-2.42]) and from external causes (3.11 [2.85-3.40]) compared to individuals without known psychiatric or substance use disorders. Suicide was the most common cause of death in younger persons. In individuals given community sentences, substance use and other psychiatric disorders were associated with an increased risk of premature death with suicide being the leading cause of death. Community supervision represents an opportunity to provide sentenced individuals with access to evidence-based treatment targeting substance misuse and psychiatric disorders to prevent potentially preventable deaths. Wellcome Trust.
Sections du résumé
Background
UNASSIGNED
Consistently high rates of premature mortality have been reported in individuals who receive community sentences. However, few studies have explored potential modifiable risk factors for these rates, particularly mental health. We examined the association of substance use and other psychiatric disorders with all-cause and external-cause mortality in individuals convicted of a criminal offence and given a community sentence.
Methods
UNASSIGNED
We did a longitudinal cohort study of 109,751 individuals given community sentences in Sweden using population-based registers. We calculated mortality rates for all-cause and external-cause mortality, hazard ratios for the association between psychiatric disorders and mortality, and population attributable fractions to quantify the contribution of psychiatric disorders to mortality risk.
Findings
UNASSIGNED
During the follow-up, 5749 (5.2%) individuals died, including 2709 (2.5%) from external causes. Individuals with pre-existing substance use and other psychiatric disorders had an increased mortality risk from any cause (aHR = 2.28 [95% CI 2.15-2.42]) and from external causes (3.11 [2.85-3.40]) compared to individuals without known psychiatric or substance use disorders. Suicide was the most common cause of death in younger persons.
Interpretation
UNASSIGNED
In individuals given community sentences, substance use and other psychiatric disorders were associated with an increased risk of premature death with suicide being the leading cause of death. Community supervision represents an opportunity to provide sentenced individuals with access to evidence-based treatment targeting substance misuse and psychiatric disorders to prevent potentially preventable deaths.
Funding
UNASSIGNED
Wellcome Trust.
Identifiants
pubmed: 37954004
doi: 10.1016/j.lanepe.2023.100703
pii: S2666-7762(23)00122-9
pmc: PMC10636268
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100703Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
We declare no competing interests.
Références
N Engl J Med. 2020 Jan 16;382(3):266-274
pubmed: 31940700
Lancet Psychiatry. 2015 May;2(5):422-430
pubmed: 26360286
Am J Public Health. 2012 Dec;102(12):e67-75
pubmed: 23078476
J Gen Intern Med. 2011 Oct;26(10):1175-82
pubmed: 21533823
Epidemiology. 2017 Jul;28(4):540-547
pubmed: 28575894
Soc Psychiatry Psychiatr Epidemiol. 2015 Jan;50(1):109-24
pubmed: 24981851
Soc Sci Med. 2018 Apr;203:74-80
pubmed: 29305018
Eur J Public Health. 2015 Oct;25(5):879-85
pubmed: 25678604
Eur J Epidemiol. 2009;24(11):659-67
pubmed: 19504049
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Acta Psychiatr Scand. 2001 Jan;103(1):45-51
pubmed: 11202128
J Subst Abuse Treat. 2022 Jun;137:108712
pubmed: 35067401
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Aust N Z J Psychiatry. 2015 Nov;49(11):1048-59
pubmed: 25999524
Diabetologia. 2022 May;65(5):800-810
pubmed: 35195735
Wellcome Open Res. 2019 Feb 11;4:28
pubmed: 31544154
J Public Health (Oxf). 2018 Mar 1;40(1):146-153
pubmed: 28159980
Sci Adv. 2019 Sep 25;5(9):eaax4043
pubmed: 31579824
Arch Toxicol. 2012 Aug;86(8):1167-231
pubmed: 22392347
Clin Rev Allergy Immunol. 2014 Feb;46(1):54-64
pubmed: 23636734
Public Health Rep. 2019 Nov/Dec;134(6):660-666
pubmed: 31603737
Mol Psychiatry. 2020 Jul;25(7):1487-1499
pubmed: 31745237
Am J Public Health. 2015 Nov;105(11):e29-49
pubmed: 26451760
PLoS One. 2019 Sep 20;14(9):e0222495
pubmed: 31539388
Lancet Public Health. 2022 Jul;7(7):e573
pubmed: 35779535
Biomolecules. 2016 Apr 15;6(2):
pubmed: 27092531
J Biomed Inform. 2020 Aug;108:103496
pubmed: 32652236
Forensic Sci Int Mind Law. 2020 Jan 1;1:100003
pubmed: 35136864
EClinicalMedicine. 2022 Jan 14;44:101266
pubmed: 35072018
JAMA Psychiatry. 2019 Feb 1;76(2):208-216
pubmed: 30516809
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Lancet Reg Health Eur. 2021 Jul 15;8:100154
pubmed: 34557852
Suicide Life Threat Behav. 1999 Summer;29(2):141-9
pubmed: 10407967